|Priority actions for the non-communicable disease crisis|
R Beaglehole, R Bonita, R Horton, C Adams, G Alleyne, P Asaria, ...
The Lancet 377 (9775), 1438-1447, 2011
|Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries|
R Moodie, D Stuckler, C Monteiro, N Sheron, B Neal, T Thamarangsi, ...
The lancet 381 (9867), 670-679, 2013
|Increased plasma tumor necrosis factor in severe alcoholic hepatitis|
GLA Bird, N Sheron, AKJ Goka, GJ Alexander, RS Williams
Annals of internal medicine 112 (12), 917-920, 1990
|Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol …|
R Williams, R Aspinall, M Bellis, G Camps-Walsh, M Cramp, A Dhawan, ...
The Lancet 384 (9958), 1953-1997, 2014
|Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease|
C Banks, A Bateman, R Payne, P Johnson, N Sheron
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
|Interleukin‐10 expression and function in experimental murine liver inflammation and fibrosis|
K Thompson, J Maltby, J Fallowfield, M McAulay, H Millward‐Sadler, ...
Hepatology 28 (6), 1597-1606, 1998
|Hepatic changes in the failing Fontan circulation|
CH Kiesewetter, N Sheron, JJ Vettukattill, N Hacking, B Stedman, ...
Heart 93 (5), 579-584, 2007
|Circulating and tissue levels of the neutrophil chemotaxin interleukin‐8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration|
N Sheron, G Bird, J Koskinas, B Portmann, M Ceska, I Lindley, R William
Hepatology 18 (1), 41-46, 1993
|Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study|
E Scorletti, L Bhatia, KG McCormick, GF Clough, K Nash, L Hodson, ...
Hepatology 60 (4), 1211-1221, 2014
|Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies|
L Pimpin, H Cortez-Pinto, F Negro, E Corbould, JV Lazarus, L Webber, ...
Journal of Hepatology 69 (3), 718-735, 2018
|Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection|
N Sheron, J Lau, H Daniels, J Goka, A Eddleston, GJM Alexander, ...
Journal of hepatology 12 (2), 241-245, 1991
|A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective|
R Burton, C Henn, D Lavoie, R O'Connor, C Perkins, K Sweeney, ...
The Lancet 389 (10078), 1558-1580, 2017
|Guidelines on the management of abnormal liver blood tests|
PN Newsome, R Cramb, SM Davison, JF Dillon, M Foulerton, EM Godfrey, ...
Gut 67 (1), 6-19, 2018
|Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin‐10 during the course of activation in vitro|
KC Thompson, A Trowern, A Fowell, M Marathe, C Haycock, MJ Arthur, ...
Hepatology 28 (6), 1518-1524, 1998
|Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis.|
N Sheron, G Bird, J Goka, G Alexander, R Williams
Clinical and experimental immunology 84 (3), 449, 1991
|Chemokine levels in human liver homogenates: Associations between GRO α and histopathological evidence of alcoholic hepatitis|
J Maltby, S Wright, G Bird, N Sheron
Hepatology 24 (5), 1156-1160, 1996
|The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals|
MA Bellis, K Hughes, J Nicholls, N Sheron, I Gilmore, L Jones
BMC public health 16 (1), 111, 2016
|Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study|
TJ Kendall, B Stedman, N Hacking, M Haw, JJ Vettukattill, AP Salmon, ...
Journal of clinical pathology 61 (4), 504-508, 2008
|Drinking patterns, dependency and life‐time drinking history in alcohol‐related liver disease|
J Hatton, A Burton, H Nash, E Munn, L Burgoyne, N Sheron
Addiction 104 (4), 587-592, 2009
|The use of interferon-α in virus infections|
NB Finter, S Chapman, P Dowd, JM Johnston, V Manna, N Sarantis, ...
Drugs 42 (5), 749-765, 1991